IRIS
BENNETT, DAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.354
NA - Nord America 4.251
AS - Asia 544
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
SA - Sud America 1
Totale 10.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.223
IT - Italia 1.704
GB - Regno Unito 1.296
IE - Irlanda 1.033
SE - Svezia 408
CN - Cina 351
FR - Francia 231
UA - Ucraina 226
DE - Germania 190
FI - Finlandia 135
ES - Italia 56
IN - India 50
VN - Vietnam 50
TR - Turchia 31
CA - Canada 27
BE - Belgio 18
HK - Hong Kong 16
PL - Polonia 13
AU - Australia 11
IR - Iran 11
SG - Singapore 11
RU - Federazione Russa 10
MK - Macedonia 7
PH - Filippine 6
CH - Svizzera 5
PT - Portogallo 5
ID - Indonesia 4
EU - Europa 3
GR - Grecia 3
JP - Giappone 3
RO - Romania 3
AZ - Azerbaigian 2
DK - Danimarca 2
KZ - Kazakistan 2
NL - Olanda 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 10.167
Salva come PNG Salva come JPEG
Città #
Southend 1.196
Dublin 1.016
Fairfield 616
Chandler 500
Ashburn 369
Woodbridge 267
Siena 258
Seattle 217
Wilmington 217
Ann Arbor 207
Cambridge 193
Jacksonville 178
Houston 174
Princeton 136
New York 109
Helsinki 106
Florence 102
Beijing 86
Milan 65
Dearborn 54
Nanjing 52
Málaga 51
Dong Ket 50
Fremont 46
Rome 44
San Mateo 43
Shanghai 40
London 38
Boardman 33
Catania 32
San Diego 30
Menlo Park 26
Izmir 24
Washington 23
Nanchang 20
Brussels 18
Shenyang 18
Gavirate 17
Guangzhou 16
Norwalk 15
Hebei 14
Padova 14
Trieste 14
Toronto 13
San Francisco 12
Arezzo 11
Jiaxing 11
Redwood City 11
Singapore 11
Changsha 10
Chicago 10
Comun Nuovo 10
Prato 10
Bologna 9
Düsseldorf 9
Kunming 9
Miami 9
Montecatini Terme 9
Napoli 9
Paris 9
Tianjin 9
Venezia 9
Bergamo 8
Cagliari 8
Frankfurt am Main 8
Hong Kong 8
Naples 8
Zhengzhou 8
Brescia 7
Como 7
Hyderabad 7
Livorno 7
Mumbai 7
Sesto Fiorentino 7
Zanjan 7
Aachen 6
Empoli 6
Figline Valdarno 6
Genova 6
Grosseto 6
Jinan 6
Lancaster 6
Ningbo 6
Pisa 6
Ponte Buggianese 6
Rubano 6
Verona 6
Central 5
Gdynia 5
Hefei 5
Kilburn 5
Moscow 5
Perugia 5
Poggibonsi 5
Salerno 5
Torino 5
Warsaw 5
Anguillara Sabazia 4
Arese 4
Atlanta 4
Totale 7.165
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 949
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 302
Exhaled nitric oxide in interstitial lung diseases 182
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 181
Antirheumatic agents in covid-19: is IL-6 the right target? 179
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 177
Peripheral biomarkers' panel for severe COVID-19 patients 176
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 174
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 170
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 169
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 168
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 166
null 165
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 160
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 154
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 152
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 148
null 145
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 144
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 141
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 136
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 135
null 134
Serum amyloid A in patients with idiopathic pulmonary fibrosis 131
Prognostic bioindicators in severe COVID-19 patients 130
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 128
Extracorporeal Photopheresis in Lung Transplantation 122
null 121
Proteomic investigation of pulmonary sarcoidosis 120
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 119
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 118
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 117
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 117
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study 116
Biomarkers in sarcoidosis: The contribution of system biology 116
New concepts in the pathogenesis of sarcoidosis 114
null 114
null 113
SARS-CoV-2 in pleural fluid in a kidney transplant patient 112
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 110
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 109
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 108
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. 108
IPF mortality in waiting list for lung transplantation 107
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 107
null 106
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 105
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 101
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 100
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 96
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 95
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 94
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 93
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 91
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 90
Chitotriosidase: a sensitive biomarker of sarcoidosis 89
BIOMARKERS WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASES 86
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 84
Familial pulmonary fibrosis: Clinical-functional and radiological features 82
IPFdatabase - A new tool for a correct application of idiopathic pulmonaty fibrosis guidelines 81
WES profiling of COVID-19 81
A first update on mapping the human genetic architecture of COVID-19 80
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 77
null 75
Outcome of ECMO bridge to lung transplantation: a single cohort study 74
Rischio infettivo nel trapianto di polmone per fibrosi polmonare: analisi retrospettiva 74
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 72
An explainable model of host genetic interactions linked to COVID-19 severity 68
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 68
Lung transplant in patients with familial pulmonary fibrosis 67
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 67
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 62
Serial KL-6 measurements in COVID-19 patients 60
The Role of Galectins in Chronic Lung Allograft Dysfunction 58
Serum Amyloid A in lung transplantation 57
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 49
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis 48
null 48
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 48
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 48
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 45
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 38
Whole-genome sequencing reveals host factors underlying critical COVID-19 38
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 38
Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed 37
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 35
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 34
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 32
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 31
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 30
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 29
Clinical and molecular characterization of COVID-19 hospitalized patients 26
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 24
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 24
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 24
null 23
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 23
NK and T cells responses to CMV in patients awaiting for lung transplantation 20
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 19
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 15
Totale 10.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019471 0 0 0 0 0 0 0 0 0 106 200 165
2019/20201.430 149 62 77 174 83 134 130 171 125 133 72 120
2020/20211.821 56 120 47 230 215 215 116 218 162 162 147 133
2021/20221.420 108 171 99 109 79 57 63 82 61 137 173 281
2022/20232.055 167 221 229 262 164 297 172 170 187 85 63 38
2023/20241.771 84 53 210 104 91 478 616 79 16 40 0 0
Totale 10.461